Press Releases IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 11:35:15 2025-07-17 EDT			5-day change	1st Jan Change
11.25 ^GBX	+15.38%		+15.38%	-4.26%

07-17	FTSE 100 closes up despite "harsh" UK jobs data	AN
07-17	FTSE 100 closes up despite "harsh" UK jobs data	AN

Press Releases

IXICO : assists first FDA clearance of new Alzheimer’s Disease blood based diagnostic biomarker	06-05	PU
IXICO : Interim results for six months ending 31 March 2025	05-20	PU
IXICO : Half year Trading update FY2025	04-16	PU
Comparison of two natural history studies as part of the HD-IH consortium: a use case for historical external control group matching in clinical trials	03-11	PU
IXICO : Huntington’s Disease consortium further validates IXICO’s AI imaging platform	02-12	PU
IXICO : Commercial agreement with PETNET Solutions Inc, a Siemens Healthineers Company	12-16	PU
IXICO : US Client Clinical Trial Contract Win	12-10	PU
Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press	24-09-05	PU
IXICO : Appointment of CEO - Bram Goorden	24-08-05	PU
IXICO : to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial	24-05-23	PU
IXICO : Huntington’s Disease Image Harmonization Consortium secures new member and funding to complete large-scale analysis of brain changes using IXIQ.Ai	23-07-12	PU
IXICO : Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET	23-04-03	PU
IXICO : AGM 2023 – Notice	22-12-16	PU
IXICO : Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease	22-12-12	PU
ANNUAL RESULTS: ANALYST PRESENTATION	22-12-09	PU
IXICO : ANNUAL REPORT 2022	22-12-06	PU
IXICO : New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease	22-09-21	PU
IXICO : INTERIM RESULTS ANALYST PRESENTATION	22-05-25	PU
IXICO : Contract award with a new client for a Huntington's Disease ('HD') trial worth circa £800,000	22-04-20	PU
CHDI's 17th Annual Therapeutics Conference: The Future of Huntington's Research	22-03-21	PU
GAP-Net Site Optimization Conference 2022: Event Review	22-03-08	PU
IXICO & GAP Foundation: Alzheimer’s & The Bio-Hermes Study	22-03-02	PU
IXICO : Discover IXIQ.Ai \| IXICO's AI-Based Brain Segmentation Platform	22-02-18	PU
IXICO : Hails The Introduction of IXIQ.Ai, Its New Brain Imaging Technology	22-02-18	PU
IXICO : Engagement In Big Data Research Dementia Collaboration	22-01-25	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Press Releases

Filters